Status:

UNKNOWN

Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy

Lead Sponsor:

The First Affiliated Hospital of Dalian Medical University

Conditions:

Diabetic Nephropathies

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This is a prospective, open, multicenter clinical trial.The objective of this study is to evaluate the efficacy and safety of Huangqi Guizhi Wuwu Decoction in patients with CKD stage 2-4 diabetic neph...

Detailed Description

The incidence rate of chronic kidney disease is 10.8% in China. The incidence rate of diabetic nephropathy has increased year by year, and now it has become the first cause of uremia. Therefore, the t...

Eligibility Criteria

Inclusion

  • Patients diagnosed as diabetic nephropathy
  • TCM syndrome differentiation is Qi deficiency and blood stasis type
  • Male or female, 18≤age≤75 4.25mL/(min.1.73m2)≤ eGFR\<90mL/(min.1.73m2) 5.24-hour urine protein ration ≤3.5g/24h
  • The participants must be capable of understanding and comply with the protocol and sign a written informed consent document

Exclusion

  • Exposure to immunosuppressors, glucocorticoid,without a one weeks washout period
  • Urinary tract infection (leukocytes in urinary sediment \> 5 / HP)
  • Serum potassium \> 5.5 mmol/L
  • Serum albumin \< 30g/L
  • Pregnant or lactating women, and participants (including males) who were unable or unwilling to take adequate contraception during the study period
  • Having comorbidities that affect the progression of diabetic nephropathy (including but not limited to Malignant tumors, Systemic autoimmune diseases, Liver cirrhosis)
  • Participating in another clinical trial
  • Investigators do not think it suitable for a participant to join this study

Key Trial Info

Start Date :

January 26 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05418465

Start Date

January 26 2022

End Date

December 31 2022

Last Update

June 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Dalian medical university

Dalian, Liaoning, China, 116011